Positive Earnings Growth Hasn't Been Enough to Get LifeTech Scientific (HKG:1302) Shareholders a Favorable Return Over the Last Three Years
If you love investing in stocks you're bound to buy some losers. Long term LifeTech Scientific Corporation (HKG:1302) shareholders know that all too well, since the share price is down considerably o
Kanghua Healthcare (03689.HK) gains 482,800 shares by Mialkos Tomasz Jakub
Glonghui, May 3 | According to the Stock Exchange's latest equity disclosure, on April 26, 2024, Kanghua Healthcare (03689.HK) received Mialkos Tomasz Jakub to increase its holdings by 482,800 shares at an average price of HK$2.10 per share on the market, involving approximately HK$1.013,900. After the increase in holdings, the latest number of shares held by Mialkos Tomasz Jakub was 4.6874 million shares, and the shareholding ratio increased from 4.98% to 5.55%.
華潤醫藥:公告有關於中國發行中期票據及公司債券的華潤醫藥控股截至2024年3月31日止三個月的未經審核財務業績
Hansoh Pharmaceutical's 2023 Profit Up 27%
Hansoh Pharmaceutical Group (HKG:3692) recorded a 27% rise in attributable profit for 2023 to 3.28 billion yuan from 2.58 billion yuan in 2022, according to the company's annual report. Earnings per s
泰凌醫藥:2023 年報
Fosun Pharma's Q1 Profit Slumps 38%
Shanghai Fosun Pharmaceutical (Group) (HKG:2196, SHA:600196) posted a net profit attributable to owners of 609.7 million yuan in the first quarter of 2024, slumping 38.2% from 987 million yuan a year